Skip to content

Heron Therapeutics, Inc.

HRTX· NasdaqCore metricsCIK 818033

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -7.30%
Market cap
$63.08M
190.27M shares
Filings
1,027
$35.25M
Q3 2026+7.4% FY25 yoy
-$5.01M
Q3 2026N/M FY25 yoy
-$1.67M
Q3 2026N/M FY25 yoy
-$5.18M
Q3 2026derivedN/M FY25 yoy
-$0.03
Q3 2026N/M FY25 yoy
$11.60M
Q3 2026+11.0% FY25 yoy
$63.08M
—
0.4×
12.8×
-22.77%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.331571.30%$0.8235past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$154.90MFY 2025
$154.90M0FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$154,904,000reported
FY 20242024-12-31$144,285,000reported
FY 20232023-12-31$127,044,000reported
FY 20222022-12-31$107,672,000reported
FY 20212021-12-31$86,346,000reported
FY 20202020-12-31$88,638,000reported
FY 20192019-12-31$145,968,000reported
FY 20182018-12-31$77,474,000reported
FY 20172017-12-31$30,767,000reported
FY 20162016-12-31$1,279,000reported

Segments

Products
Revenue by Products, FY2019 to FY2025FY2019CINVANTI · FY2019 · $132.16MSUSTOL · FY2019 · $13.81MFY2020CINVANTI · FY2020 · $87.82MSUSTOL · FY2020 · $823.00KFY2021CINVANTI · FY2021 · $73.51MZYNRELEF · FY2021 · $2.92MSUSTOL · FY2021 · $9.92MFY2022CINVANTI · FY2022 · $87.25MZYNRELEF · FY2022 · $10.20MSUSTOL · FY2022 · $10.23MFY2023CINVANTI · FY2023 · $94.87MZYNRELEF · FY2023 · $17.73MAPONVIE · FY2023 · $1.39MSUSTOL · FY2023 · $13.06MFY2024CINVANTI · FY2024 · $100.08MZYNRELEF · FY2024 · $25.55MAPONVIE · FY2024 · $4.52MSUSTOL · FY2024 · $14.14MFY2025CINVANTI · FY2025 · $96.76MZYNRELEF · FY2025 · $38.07MAPONVIE · FY2025 · $11.57MSUSTOL · FY2025 · $8.50M
LineFY2025ShareChange
CINVANTI$96.76M62%−3.3%
ZYNRELEF$38.07M25%+49.0%
APONVIE$11.57M7.5%+156.1%
SUSTOL$8.50M5.5%−39.9%
Total$154.90M

From the 10-K filed Feb 26, 2026HRTX

Pharmaceutical preparations

Heron Therapeutics, Inc. is the 94th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR